Logo for Biotest Aktiengesellschaft

Biotest Investor Relations Material

Latest events

Logo for Biotest Aktiengesellschaft

H2 2022

Biotest
Logo for Biotest

Q3 2024

8 Nov, 2024
Logo for Biotest

H1 2024

6 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Biotest Aktiengesellschaft

Access all reports
Biotest Aktiengesellschaft is a German-based company that specializes in the development, production, and marketing of plasma proteins and biological drugs. The company’s primary focus areas include clinical immunology, hematology, and intensive care medicine. Biotest’s product portfolio includes immunoglobulins, coagulation factors, and albumins, which are derived from human blood plasma and are utilized in treating immune and hematopoietic system disorders. Additionally, the company engages in the development of monoclonal antibodies for treating conditions such as cancer of plasma cells and systemic lupus erythematosus. The company is headquartered in Dreieich, Germany, and its shares are listed on the Frankfurt Stock Exchange.